Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine.

TitleInhibition of the proliferation of human neural neoplastic cell lines by cysteamine.
Publication TypeJournal Article
Year of Publication1996
AuthorsJeitner TM, Renton FJ
JournalCancer Lett
Volume103
Issue1
Pagination85-90
Date Published1996 May 15
ISSN0304-3835
KeywordsBlood-Brain Barrier, Brain Neoplasms, Cell Cycle, Cell Division, Cell Line, Cysteamine, DNA, Neoplasm, Dose-Response Relationship, Drug, G2 Phase, Glioma, Humans, Kinetics, Mitosis, Neuroblastoma, Penicillamine, S Phase, Thymidine, Time Factors, Tumor Cells, Cultured
Abstract

Cysteamine (CySH), a thiol compound that crosses the blood-brain barrier, inhibited the proliferation of neural neoplastic cells in vitro. The IC50 of cysteamine with respect to inhibition after 72 h of drug exposure, was approximately 70 microM in the glioma cell line, 2607, and approximately 80 microM in the neuroblastoma cell line, DAOY. Interestingly, the inhibition of proliferation of 2607 cells produced by 72 h treatment with CySH could also be induced with exposure periods as short as 8 h. Another thiol bearing compound, penicillamine methyl ester, also arrested the proliferation of 2607 cells with IC50 approximately 160 microM. Cell cycle analysis revealed that CySH acted to lengthen the cell cycle period of 2607 cells by slowing the passage of cells through S phase and caused the cells to finally arrest in G2/M. In the other cell lines tested, CySH arrested cells in all phases of the cell cycle. These observations suggest that CySH and its congeners may have some utility in the treatment of neoplasia in vivo.

DOI10.1016/0304-3835(96)04200-0
Alternate JournalCancer Lett
PubMed ID8616813
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065